We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 50,000 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/7/2018 15:58 | And the biggest reality is that if Nuvec is successful then it will be valued in multiples of all the other reformulations put together if it becomes the industry standard. So far Nuvec has exceeded all expectations which is why we have the collaboration with Medimmune who are working with N4 to make Nuvec succeed. | hughwilson | |
22/7/2018 15:43 | The market for Viagra has grown by 60% since viagra went OTC three months ago and this figure is increasing. Such is the goal for N4 and yet here it is suggested that N4 will just ditch their formulation without any reference to the final report whatsoever. The reality as you put it is that nobody including Nigel knows if it is going to be an easy tweak or not. The reality is that Nigel will wait for the final report. The reality is that if it can be tweaked then it will be. The reality is that N4 has not given up on sildenafil. The reality is that given the huge and increasing market, only an idiot would give up at the first fence without looking at the data. The reality is that we have Nigel in charge with a wealth of experience having done this all before and yet we have those here who think they know so much better but ONLY with hindsight. | hughwilson | |
21/7/2018 11:14 | >> dplewis Effort in, effort out. Given long enough and enough money I am pretty sure they could sort out the formulation. However, until we see what the issue was we won't know whether there is any chance of just tweaking the current formulation. I somehow doubt it but you never know. So at the moment I think it is impossible to know the % chance in the short term. Nobby | nobbygnome | |
21/7/2018 09:51 | Nobby what would you call a good chance of success for a reformulation, 15-20%? I've put the sildenafil down to about 5% after the negative wording in the RNS.I've got a subscription so not sure if you can watch this vid but it's quite interesting how some startups are de-stigmatising conditions such as ED, PE and baldness. If only N4 could get a drug to market..!https://www | dplewis1 | |
21/7/2018 08:46 | >> hugh Sadly I am still a shareholder. However, I am a realist. The best way forward is to move on to other products with a better chance of success. | nobbygnome | |
20/7/2018 21:44 | escapetohome, I think you will find that I call a spade a spade or in your case a de-ramper. Anyway, enjoy it while you can because the bounce will be on soon enough and all the de-rampers will evaporate faster than the morning mist. | hughwilson | |
20/7/2018 19:18 | Hughwilson, stop the paranoid posts. Please think before you post. Filtered. | escapetohome | |
20/7/2018 19:17 | Well done dp lewis ,totally correct. I dont trust hugh wilson one inch. Sell. | escapetohome | |
20/7/2018 14:55 | Crikey, what a ridiculous price. OVERSOLD. Definitely time to buy:))) | ch1rp | |
20/7/2018 14:27 | right now the rotten black sheep of my portfolio .. hope fortunes change Just shows you how much money was invested on Sildenafil rather than Nuvec | onedayrodders | |
20/7/2018 10:02 | I think the lack of anything substantial to talk about regarding N4P has brought about a surfeit of drivel across all platforms. At least the sight of Hugh chastising someone for 'de-ramping' has brought some humour to the occasion. | dplewis1 | |
20/7/2018 09:51 | It may be an aggressive response, but people returning 3 days after selling with an 'I told you so' deserve to be snapped at. Grow up. | jpsbax | |
20/7/2018 09:40 | plewis1, It actually reads " better to sell" which is advise and therefore against regulations. It is a plain de ramp nonetheless. | hughwilson | |
20/7/2018 09:34 | Hugh, do you actually read things properly before you aggressively respond? I'm pretty sure the post from the 17th reads "I sold out" and then the post from today is meaning "I'm glad I sold out because it has declined further". Also your "stream of 100k buys" is a grand total of 3.. which is about 28 grand, so of very little consequence. | dplewis1 | |
20/7/2018 08:44 | Just as i thought , better to sell, after that disappointing rns. All hinges on nuvec. I dont want that risk. | escapetohome | |
20/7/2018 08:41 | 5p by Christmas.It's a failure. | ken chung | |
17/7/2018 13:52 | What was he prior? | turbotrader2 | |
17/7/2018 13:36 | You mean this David Farrier RNS? Yes it's an existing holder increasing (substantially) his stake. | dplewis1 | |
17/7/2018 13:24 | Can anyone point me in the right direction? Is this increased | turbotrader2 | |
17/7/2018 13:15 | Lol, the people who run this company own the company. The only way this share is going is UP!!!! | ch1rp | |
17/7/2018 12:04 | Im out, that should help. | escapetohome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions